GlassScriptPhysician profile
Felice Cellini
NPI 1639411861
$843.70
in general payments reported to CMS, 2019-2025
21 companies · $48.43 in 2025
The $48.43 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $220 · 2022: $146 · 2023: $377 · 2024: $52.64 · 2025: $48.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $95.00 | 2021-2024 | Tepezza, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $89.77 | 2021-2025 | |
| Lilly USA, LLC | $79.55 | 2021-2023 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.00 | 2021-2024 | Jardiance |
| Xeris Pharmaceuticals, INC. | $60.57 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $48.58 | 2023 | |
| Novo Nordisk INC | $45.39 | 2022-2023 | Rybelsus |
| Abbvie INC. | $44.74 | 2021-2023 | |
| Idorsia Pharmaceuticals US INC | $43.41 | 2023 | Quviviq |
| Exact Sciences Corporation | $40.32 | 2023 | Cologuard Collection Kit |
| Tandem Diabetes Care, INC. | $28.97 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.21 | 2021-2023 | Xifaxan |
| Ani Pharmaceuticals, INC. | $26.98 | 2023 | Purified Cortrophin Gel |
| Pfizer INC. | $26.27 | 2021 | |
| Madrigal Pharmaceuticals | $23.43 | 2025 | Rezdiffra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $19.12 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.86 | 2023 | Xarelto |
| Philips North America LLC | $17.05 | 2022 | |
| Amarin Pharma, INC. | $15.11 | 2022 | |
| Insulet Corporation | $14.75 | 2021 | |
| Corcept Therapeutics | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felice Cellini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.